EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy

Bibliographic Details
Title: EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
Authors: Traub-Weidinger, Tatjana, Arbizu, Javier, Barthel, Henryk, Boellaard, Ronald, Borgwardt, Lise, Brendel, Matthias, Cecchin, Diego, Chassoux, Francine, Fraioli, Francesco, Garibotto, Valentina, Guedj, Eric, Hammers, Alexander, Law, Ian, Morbelli, Silvia, Tolboom, Nelleke, Van Weehaeghe, Donatienne, Verger, Antoine, Van Paesschen, Wim, von Oertzen, Tim J., Zucchetta, Pietro, Semah, Franck
Contributors: MS Radiologie, Brain, Cancer, Ferrand, Patrick
Source: Eur J Nucl Med Mol Imaging
Traub-Weidinger, T, Arbizu, J, Barthel, H, Boellaard, R, Borgwardt, L, Brendel, M, Cecchin, D, Chassoux, F, Fraioli, F, Garibotto, V, Guedj, E, Hammers, A, Law, I, Morbelli, S, Tolboom, N, van Weehaeghe, D, Verger, A, van Paesschen, W, von Oertzen, T J, Zucchetta, P & Semah, F 2024, 'EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy', European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 7, pp. 1891-1908. https://doi.org/10.1007/s00259-024-06656-3
European journal of nuclear medicine and molecular imaging 51(7), 1891-1908 (2024). doi:10.1007/s00259-024-06656-3
Publisher Information: Springer Science and Business Media LLC, 2024.
Publication Year: 2024
Subject Terms: Drug-resistant epilepsy, Extratemporal epilepsy, Focal epilepsy, Ictal SPECT, Imaging, Interictal SPECT, MRI, Neurotransmitter PET, Paediatric epileptic syndromes, Presurgical evaluation, Surgery, Temporal lobe epilepsy, [, 18, F]FDG PET, TEMPORAL-LOBE EPILEPSY, TUBEROUS SCLEROSIS COMPLEX, FDG-PET/MRI COREGISTRATION, DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS, 616.0757, Radiology, Nuclear Medicine & Medical Imaging, methods [Positron-Emission Tomography], ICTAL SPECT, [ F]FDG PET, LENNOX-GASTAUT-SYNDROME, 3. Good health, [18F]FDG PET, Europe, Nuclear Medicine & Medical Imaging, Radiology Nuclear Medicine and imaging, CEREBRAL GLUCOSE-METABOLISM, diagnostic imaging [Epilepsy], Life Sciences & Biomedicine, Europe [MeSH], Tomography, Emission-Computed, Single-Photon [MeSH], Humans [MeSH], Guidelines, Epilepsy/diagnostic imaging [MeSH], Positron-Emission Tomography/standards [MeSH], Positron-Emission Tomography/methods [MeSH], Nuclear Medicine [MeSH], 0299 Other Physical Sciences, [F-18]FDG PET, standards [Positron-Emission Tomography], [SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine, POSITRON-EMISSION-TOMOGRAPHY, FOCAL CORTICAL DYSPLASIA, Humans, ddc:610, STURGE-WEBER SYNDROME, Tomography, Emission-Computed, Single-Photon, Science & Technology, Epilepsy, 1103 Clinical Sciences, Positron-Emission Tomography, Nuclear Medicine
Description: Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of more than 50 million people worldwide and an annual incidence of two million. Although pharmacotherapy with anti-seizure medication (ASM) is the treatment of choice, ~30% of patients with epilepsy do not respond to ASM and become drug resistant. Focal epilepsy is the most frequent form of epilepsy. In patients with drug-resistant focal epilepsy, epilepsy surgery is a treatment option depending on the localisation of the seizure focus for seizure relief or seizure freedom with consecutive improvement in quality of life. Beside examinations such as scalp video/electroencephalography (EEG) telemetry, structural, and functional magnetic resonance imaging (MRI), which are primary standard tools for the diagnostic work-up and therapy management of epilepsy patients, molecular neuroimaging using different radiopharmaceuticals with single-photon emission computed tomography (SPECT) and positron emission tomography (PET) influences and impacts on therapy decisions. To date, there are no literature-based praxis recommendations for the use of Nuclear Medicine (NM) imaging procedures in epilepsy. The aims of these guidelines are to assist in understanding the role and challenges of radiotracer imaging for epilepsy; to provide practical information for performing different molecular imaging procedures for epilepsy; and to provide an algorithm for selecting the most appropriate imaging procedures in specific clinical situations based on current literature. These guidelines are written and authorized by the European Association of Nuclear Medicine (EANM) to promote optimal epilepsy imaging, especially in the presurgical setting in children, adolescents, and adults with focal epilepsy. They will assist NM healthcare professionals and also specialists such as Neurologists, Neurophysiologists, Neurosurgeons, Psychiatrists, Psychologists, and others involved in epilepsy management in the detection and interpretation of epileptic seizure onset zone (SOZ) for further treatment decision. The information provided should be applied according to local laws and regulations as well as the availability of various radiopharmaceuticals and imaging modalities.
Document Type: Article
Other literature type
File Description: application/pdf
Language: English
ISSN: 1619-7089
1619-7070
DOI: 10.1007/s00259-024-06656-3
Access URL: https://pubmed.ncbi.nlm.nih.gov/38393374
https://research.vumc.nl/en/publications/18fed0cb-fc61-4551-9177-4da3cc28fd56
https://dspace.library.uu.nl/handle/1874/453779
https://archive-ouverte.unige.ch/unige:177274
https://doi.org/10.1007/s00259-024-06656-3
https://hdl.handle.net/11577/3512081
https://doi.org/10.1007/s00259-024-06656-3
https://repository.publisso.de/resource/frl:6518891
https://epub.ub.uni-muenchen.de/117672/
https://discovery-pp.ucl.ac.uk/id/eprint/10188667/
Rights: CC BY
Accession Number: edsair.doi.dedup.....68148b901b9368a162eecc67850cdda0
Database: OpenAIRE
Description
ISSN:16197089
16197070
DOI:10.1007/s00259-024-06656-3